Table of Contents

2019-2024 Global Metagenomics in Healthcare Market Report (Status and Outlook)

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Metagenomics in Healthcare Market Size 2014-2024
  • 2.1.2 Metagenomics in Healthcare Market Size CAGR by Region
• 2.2 Metagenomics in Healthcare Segment by Type
  • 2.2.1 Sample Extraction Kits
  • 2.2.2 Metagenomics Kits
• 2.3 Metagenomics in Healthcare Market Size by Type
  • 2.3.1 Global Metagenomics in Healthcare Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Metagenomics in Healthcare Market Size Growth Rate by Type (2014-2019)
• 2.4 Metagenomics in Healthcare Segment by Application
  • 2.4.1 Pharmaceutical Industries
  • 2.4.2 Biotechnology Companies
  • 2.4.3 Pathology Laboratories
  • 2.4.4 Academic and Research Laboratories
  • 2.4.5 Others
• 2.5 Metagenomics in Healthcare Market Size by Application
  • 2.5.1 Global Metagenomics in Healthcare Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Metagenomics in Healthcare Market Size Growth Rate by Application (2014-2019)

3 Global Metagenomics in Healthcare by Players

• 3.1 Global Metagenomics in Healthcare Market Size Market Share by Players
  • 3.1.1 Global Metagenomics in Healthcare Market Size by Players (2017-2019)
  • 3.1.2 Global Metagenomics in Healthcare Market Size Market Share by Players (2017-2019)
• 3.2 Global Metagenomics in Healthcare Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Metagenomics in Healthcare by Regions

• 4.1 Metagenomics in Healthcare Market Size by Regions
• 4.2 Americas Metagenomics in Healthcare Market Size Growth
• 4.3 APAC Metagenomics in Healthcare Market Size Growth
• 4.4 Europe Metagenomics in Healthcare Market Size Growth
• 4.5 Middle East & Africa Metagenomics in Healthcare Market Size Growth

5 Americas

• 5.1 Americas Metagenomics in Healthcare Market Size by Countries
• 5.2 Americas Metagenomics in Healthcare Market Size by Type
• 5.3 Americas Metagenomics in Healthcare Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Metagenomics in Healthcare Market Size by Countries
• 6.2 APAC Metagenomics in Healthcare Market Size by Type
• 6.3 APAC Metagenomics in Healthcare Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Metagenomics in Healthcare by Countries
• 7.2 Europe Metagenomics in Healthcare Market Size by Type
• 7.3 Europe Metagenomics in Healthcare Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Metagenomics in Healthcare by Countries
• 8.2 Middle East & Africa Metagenomics in Healthcare Market Size by Type
• 8.3 Middle East & Africa Metagenomics in Healthcare Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Metagenomics in Healthcare Market Forecast

• 10.1 Global Metagenomics in Healthcare Market Size Forecast (2019-2024)
• 10.2 Global Metagenomics in Healthcare Forecast by Regions
  • 10.2.1 Global Metagenomics in Healthcare Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Metagenomics in Healthcare Forecast by Type
• 10.8 Global Metagenomics in Healthcare Forecast by Application

11 Key Players Analysis

• 11.1 Illumina
  • 11.1.1 Company Details
  • 11.1.2 Metagenomics in Healthcare Product Offered
  • 11.1.3 Illumina Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 Illumina News
• 11.2 QIAGEN
  • 11.2.1 Company Details
  • 11.2.2 Metagenomics in Healthcare Product Offered
  • 11.2.3 QIAGEN Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 QIAGEN News
• 11.3 PerkinElmer
  • 11.3.1 Company Details
  • 11.3.2 Metagenomics in Healthcare Product Offered
  • 11.3.3 PerkinElmer Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 PerkinElmer News
• 11.4 Thermo Fisher Scientific
  • 11.4.1 Company Details
  • 11.4.2 Metagenomics in Healthcare Product Offered
  • 11.4.3 Thermo Fisher Scientific Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 Thermo Fisher Scientific News
• 11.5 Oxford Nanopore Technologies
  • 11.5.1 Company Details
  • 11.5.2 Metagenomics in Healthcare Product Offered
  • 11.5.3 Oxford Nanopore Technologies Metagenomics in Healthcare Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 Oxford Nanopore Technologies News

...

12 Research Findings and Conclusion

Metagenomics is the study of genetic material recovered directly from environmental samples.

According to this study, over the next five years the Metagenomics in Healthcare market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Metagenomics in Healthcare business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Metagenomics in Healthcare market by product type, application, key companies and key regions.

This study considers the Metagenomics in Healthcare value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Sample Extraction Kits
Metagenomics Kits
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Pharmaceutical Industries
Biotechnology Companies
Pathology Laboratories
Academic and Research Laboratories
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Illumina
QIAGEN
PerkinElmer
Thermo Fisher Scientific
Oxford Nanopore Technologies
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Metagenomics in Healthcare market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Metagenomics in Healthcare market by identifying its various subsegments.
Focuses on the key global Metagenomics in Healthcare players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Metagenomics in Healthcare with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Metagenomics in Healthcare submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.